Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors

被引:70
作者
Schlicker, E [1 ]
Werthwein, S [1 ]
Kathmann, M [1 ]
Bauer, U [1 ]
机构
[1] Univ Bonn, Inst Pharmakol & Toxikol, D-53113 Bonn, Germany
关键词
nociceptin; orphanin FQ; ORL1; receptor; noradrenaline release; mouse brain cortex; presynaptic receptors;
D O I
10.1007/PL00005273
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A fourth type of opioid receptor, termed ORL1, has been cloned and nociceptin (also known as orphanin FQ) has been identified as an endogenous ligand at this receptor. We examined whether nociceptin affects the release of noradrenaline in the brain. For this purpose, cerebral cortex slices from the mouse, rat or guinea-pig were preincubated with [H-3]noradrenaline and then superfused with medium containing desipramine and rauwolscine, Tritium overflow was evoked electrically (0.3 Hz) or by introduction of Ca2+ 1.3 mM into Ca2+-free K+-rich (15 mM) medium. Nociceptin 1 mu M reduced the electrically evoked tritium overflow from mouse, rat and guinea-pig brain cortex slices by 80, 71 and 36%, respectively Naloxone 10 mu M did not change the effect of nociceptin. All subsequent experiments were performed on mouse brain cortex slices and in the presence of naloxone 10 mu M. The concentration-response curve of nociceptin (maximum inhibition by 80%, pEC(50) 7.5) was shifted to the tight by the non-selective ORL1 receptor antagonist naloxone benzoylhydrazone and the selective ORL1 receptor antagonist [Phe(1)psi(CH2-NH)Gly(2)]-nociceptin(1-13)NH2 (pA(2) 6.6 and 7.2, respectively). Naloxone benzoylhydrazone did not affect the evoked overflow by itself whereas [Phe(1)psi(CH2-NH)Gly(2)]-nociceptin(1-13)NH2 caused an inhibition by maximally 35% (pEC(50) 7.0; intrinsic activity alpha 0.45). The inhibitory effect of [Phe(1)psi(CH2-NH)Gly(2)]-nociceptin(1-13)NH2 was counteracted by naloxone benzoylhydrazone. Nociceptin also reduced the Ca2+-evoked tritium overflow in mouse brain cortex slices superfused in the presence of tetrodotoxin. This effect was also antagonized by naloxone benzoylhydrazone, which, by itself, did not affect the evoked tritium overflow. In conclusion, nociceptin inhibits noradrenaline release more markedly in the mouse than in the rat or guinea-pig brain cortex. The effect of nociceptin in the mouse brain cortex involves ORL1 receptors, which are located presynaptically on noradrenergic neurones.
引用
收藏
页码:418 / 422
页数:5
相关论文
共 47 条
  • [21] Orphanin FQ/nociceptin binds to functionally coupled ORL1 receptors on human immune cell lines and alters peripheral blood mononuclear cell proliferation
    Peluso, J
    Gavériaux-Ruff, C
    Matthes, HWD
    Filliol, D
    Kieffer, BL
    BRAIN RESEARCH BULLETIN, 2001, 54 (06) : 655 - 660
  • [22] HISTAMINE-H3A RECEPTOR-MEDIATED INHIBITION OF NORADRENALINE RELEASE IN THE MOUSE-BRAIN CORTEX
    SCHLICKER, E
    BEHLING, A
    LUMMEN, G
    GOTHERT, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1992, 345 (04) : 489 - 493
  • [23] PROSTANOID RECEPTORS OF THE EP(3) SUBTYPE MEDIATE THE INHIBITORY EFFECT OF PROSTAGLANDIN E(2) ON NORADRENALINE RELEASE IN THE MOUSE-BRAIN CORTEX
    EXNER, HJ
    SCHLICKER, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1995, 351 (01) : 46 - 52
  • [24] MODULATION OF N-METHYL-D-ASPARTATE (NMDA)-STIMULATED NORADRENALINE RELEASE IN RAT-BRAIN CORTEX BY PRESYNAPTIC ALPHA-2-ADRENOCEPTORS
    FINK, K
    GOTHERT, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1993, 348 (04) : 372 - 378
  • [25] PROTEIN-KINASE-C INVOLVEMENT IN MAINTENANCE AND MODULATION OF NORADRENALINE RELEASE IN THE MOUSE-BRAIN CORTEX
    SCHROEDER, GE
    KOTSONIS, P
    MUSGRAVE, IF
    MAJEWSKI, H
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (06) : 2757 - 2763
  • [26] Effects of the neoclerodane Hardwickiic acid on the presynaptic opioid receptors which modulate noradrenaline and dopamine release in mouse central nervous system
    Pittaluga, Anna
    Olivero, Guendalina
    Di Prisco, Silvia
    Merega, Elisa
    Bisio, Angela
    Romussi, Giovanni
    Grilli, Massimo
    Marchi, Mario
    NEUROCHEMISTRY INTERNATIONAL, 2013, 62 (04) : 354 - 359
  • [27] PRESYNAPTIC NORADRENERGIC ALPHA-RECEPTORS AND MODULATION OF H-3-NORADRENALINE RELEASE FROM RAT-BRAIN SYNAPTOSOMES
    DELANGEN, CDJ
    HOGENBOOM, F
    MULDER, AH
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 60 (01) : 79 - 89
  • [28] Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings
    Raiteri, L.
    Luccini, E.
    Romei, C.
    Salvadori, S.
    Calo, G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (03) : 474 - 481
  • [29] Noradrenaline release-inhibiting receptors on PC12 cells devoid of α2- and CB1 receptors:: similarities to presynaptic imidazoline and edg receptors
    Molderings, GJ
    Bönisch, H
    Hammermann, R
    Göthert, M
    Brüss, M
    NEUROCHEMISTRY INTERNATIONAL, 2002, 40 (02) : 157 - 167
  • [30] Kainate receptors are involved in the glutamate-induced indirect, purinergic inhibition of [H-3] noradrenaline release in rabbit brain cortex
    vonKugelgen, I
    Starke, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1995, 353 (01) : 46 - 54